Beyond Medical Technologies Stock Analysis

DOCKF Stock  USD 0.26  0.09  53.79%   
Below is the normalized historical share price chart for Beyond Medical Technologies extending back to April 11, 2012. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Beyond Medical stands at 0.26, as last reported on the 9th of February, with the highest price reaching 0.26 and the lowest price hitting 0.17 during the day.
200 Day MA
0.2616
50 Day MA
0.1583
Beta
9.2 K
 
Yuan Drop
 
Covid
 
Interest Hikes
Beyond Medical Techn holds a debt-to-equity ratio of 0.042. At this time, Beyond Medical's Debt To Assets are most likely to increase slightly in the upcoming years. The Beyond Medical's current Debt Ratio is estimated to increase to 4.11, while Short and Long Term Debt is projected to decrease to roughly 49.5 K. Beyond Medical's financial risk is the risk to Beyond Medical stockholders that is caused by an increase in debt.

Asset vs Debt

Equity vs Debt

Beyond Medical's liquidity is one of the most fundamental aspects of both its future profitability and its ability to meet different types of ongoing financial obligations. Beyond Medical's cash, liquid assets, total liabilities, and shareholder equity can be utilized to evaluate how much leverage the Company is using to sustain its current operations. For traders, higher-leverage indicators usually imply a higher risk to shareholders. In addition, it helps Beyond Stock's retail investors understand whether an upcoming fall or rise in the market will negatively affect Beyond Medical's stakeholders.
For many companies, including Beyond Medical, marketable securities, inventories, and receivables are the most common assets that could be converted to cash. However, for Beyond Medical Technologies, the most critical issue when managing liquidity is ensuring that current assets are properly aligned with current liabilities. If they are not, Beyond Medical's management will need to obtain alternative financing to ensure there are always enough cash equivalents on the balance sheet to meet obligations.
Price Book
3.9589
Enterprise Value Ebitda
0.0393
Price Sales
1.4133
Shares Float
17.3 M
Wall Street Target Price
27.98
Given that Beyond Medical's debt-to-equity ratio measures a Company's obligations relative to the value of its net assets, it is usually used by traders to estimate the extent to which Beyond Medical is acquiring new debt as a mechanism of leveraging its assets. A high debt-to-equity ratio is generally associated with increased risk, implying that it has been aggressive in financing its growth with debt. Another way to look at debt-to-equity ratios is to compare the overall debt load of Beyond Medical to its assets or equity, showing how much of the company assets belong to shareholders vs. creditors. If shareholders own more assets, Beyond Medical is said to be less leveraged. If creditors hold a majority of Beyond Medical's assets, the Company is said to be highly leveraged.
The current Common Stock is estimated to decrease to about 17 M. The Beyond Medical's current Total Stockholder Equity is estimated to increase to about (530.7 K). The Beyond Medical's current Price Earnings To Growth Ratio is estimated to increase to 19.02, while Price To Sales Ratio is projected to decrease to 3.49.
Beyond Medical Technologies is overvalued with Real Value of 0.14 and Hype Value of 0.17. The main objective of Beyond Medical stock analysis is to determine its intrinsic value, which is an estimate of what Beyond Medical Technologies is worth, separate from its market price. There are two main types of Beyond Medical's stock analysis: fundamental analysis and technical analysis.
The Beyond Medical stock is traded in the USA on OTCCE Exchange, with the market opening at 09:30:00 and closing at 16:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in the USA. Here, you can get updates on important government artifacts, including earning estimates, SEC corporate filings, announcements, and Beyond Medical's ongoing operational relationships across important fundamental and technical indicators.
Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Beyond Medical Technologies. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in employment.

Beyond Stock Analysis Notes

About 35.0% of the company shares are held by company insiders. The book value of Beyond Medical was currently reported as 0.04. The company recorded a loss per share of 0.07. Beyond Medical Techn last dividend was issued on the 12th of May 2020. The entity had 1:10 split on the 30th of December 2022. Beyond Medical Technologies Inc. engages in the manufacturing and distribution of personal protective equipment in Canada. The company was incorporated in 2006 and is headquartered in Vancouver, Canada. Beyond Med is traded on OTC Exchange in the United States. To learn more about Beyond Medical Technologies call Kulwant Malhi at 778-200-4124 or check out https://republictech.io.

Beyond Medical Techn Investment Alerts

Beyond Medical Techn is way too risky over 90 days horizon
Beyond Medical Techn has some characteristics of a very speculative penny stock
Beyond Medical Techn appears to be risky and price may revert if volatility continues
Beyond Medical Techn has high likelihood to experience some financial distress in the next 2 years
Net Loss for the year was (285.94 K) with loss before overhead, payroll, taxes, and interest of (250.49 K).
Beyond Medical Technologies has accumulated about 877.31 K in cash with (109.77 K) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.01.
Beyond Medical Techn has a frail financial position based on the latest SEC disclosures
Roughly 35.0% of the company shares are held by company insiders
Latest headline from news.google.com: GE HealthCare Technologies Is Quietly Exploding Heres What Wall Street Isnt Telling You - AD HOC NEWS

Beyond Medical Thematic Classifications

In addition to having Beyond Medical stock in your portfolios, you can add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your favorite investment opportunity, you can then obtain an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility. If you are a result-oriented investor, you can benefit from optimizing one of our existing themes to build an efficient portfolio against your specific investing outlook.
Drugs Idea
Drugs
Drug manufacturing and delivery

Beyond Market Capitalization

The company currently falls under 'Micro-Cap' category with a current market capitalization of 12.65 M.

Beyond Profitablity

Last ReportedProjected for Next Year
Return On Tangible Assets(0.02)(0.02)
Return On Capital Employed 0.64  0.67 
Return On Assets(0.02)(0.02)

Management Efficiency

Beyond Medical Techn has return on total asset (ROA) of (0.2011) % which means that it has lost $0.2011 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of (3.1401) %, meaning that it generated substantial loss on money invested by shareholders. Beyond Medical's management efficiency ratios could be used to measure how well Beyond Medical manages its routine affairs as well as how well it operates its assets and liabilities. At this time, Beyond Medical's Return On Capital Employed is most likely to increase slightly in the upcoming years. The Beyond Medical's current Return On Equity is estimated to increase to 0.0004, while Return On Tangible Assets are projected to decrease to (0.02). At this time, Beyond Medical's Fixed Asset Turnover is most likely to increase in the upcoming years.
Last ReportedProjected for Next Year
Book Value Per Share(0.09)(0.09)
Tangible Book Value Per Share(0.09)(0.09)
Enterprise Value Over EBITDA(1.02)(1.07)
Price Book Value Ratio(0.40)(0.38)
Enterprise Value Multiple(1.02)(1.07)
Price Fair Value(0.40)(0.38)
Enterprise Value291.4 K306 K
Understanding the management dynamics of Beyond Medical Technologies allows us to gauge its ability to sustain growth and profitability. This comprehensive analysis aids in determining the stock's value.
Beta
9.2 K
Return On Assets
(0.20)
Return On Equity
(3.14)

Technical Drivers

As of the 9th of February, Beyond Medical shows the Mean Deviation of 23.88, risk adjusted performance of 0.1342, and Downside Deviation of 59.69. Beyond Medical Techn technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices. Please confirm Beyond Medical Techn value at risk, as well as the relationship between the semi variance and kurtosis to decide if Beyond Medical Techn is priced correctly, providing market reflects its regular price of 0.26144999 per share. As Beyond Medical Techn appears to be a penny stock we also recommend to validate its total risk alpha numbers.

Beyond Medical Techn Price Movement Analysis

Illegal number of arguments. The output start index for this execution was zero with a total number of output elements of zero. The Weighted Moving Average calculates a weight for each value in Beyond Medical price series with the more recent values given greater weights.

Beyond Medical Predictive Daily Indicators

Beyond Medical intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Beyond Medical stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.

Beyond Medical Forecast Models

Beyond Medical's time-series forecasting models are one of many Beyond Medical's stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Beyond Medical's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

Beyond Medical Financial Rating

Beyond Medical Technologies financial ratings play a critical role in determining how much Beyond Medical have to pay to access credit markets, i.e., the amount of interest on their issued debt. The threshold between investment-grade and speculative-grade ratings has important market implications for Beyond Medical's borrowing costs.
Piotroski F Score
2
FrailView
Beneish M Score
(162.26)
Unlikely ManipulatorView

Beyond Medical Techn Debt to Cash Allocation

Many companies such as Beyond Medical, eventually find out that there is only so much market out there to be conquered, and adding the next product or service is only half as profitable per unit as their current endeavors. Eventually, the company will reach a point where cash flows are strong, and extra cash is available but not fully utilized. In this case, the company may start buying back its stock from the public or issue more dividends.
Beyond Medical Technologies has accumulated 60 K in total debt with debt to equity ratio (D/E) of 0.04, which may suggest the company is not taking enough advantage from borrowing. Beyond Medical Techn has a current ratio of 3.66, suggesting that it is liquid and has the ability to pay its financial obligations in time and when they become due. Note, when we think about Beyond Medical's use of debt, we should always consider it together with its cash and equity.

Beyond Medical Total Current Liabilities Over Time

Beyond Medical Assets Financed by Debt

The debt-to-assets ratio shows the degree to which Beyond Medical uses debt to finance its assets. It includes both long-term and short-term borrowings maturing within one year. It also includes both tangible and intangible assets, such as goodwill.

Beyond Medical Debt Ratio

    
  411.0   
It seems as most of the Beyond Medical's assets are financed through debt. Typically, companies with high debt-to-asset ratios are said to be highly leveraged. The higher the ratio, the greater risk will be associated with the Beyond Medical's operation. In addition, a high debt-to-assets ratio may indicate a low borrowing capacity of Beyond Medical, which in turn will lower the firm's financial flexibility.

Beyond Short Long Term Debt

Short Long Term Debt

49,500

At this time, Beyond Medical's Short and Long Term Debt is most likely to increase significantly in the upcoming years.

About Beyond Stock Analysis

Stock analysis is the technique used by a trader or investor to examine and evaluate how Beyond Medical prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Beyond shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Beyond Medical. By using and applying Beyond Stock analysis, traders can create a robust methodology for identifying Beyond entry and exit points for their positions.
Last ReportedProjected for Next Year
Pretax Profit Margin(1.78)(1.87)
Operating Profit Margin(1.40)(1.47)
Net Loss(2.78)(2.92)
Gross Profit Margin(0.24)(0.25)

Be your own money manager

As an investor, your ultimate goal is to build wealth. Optimizing your investment portfolio is an essential element in this goal. Using our stock analysis tools, you can find out how much better you can do when adding Beyond Medical to your portfolios without increasing risk or reducing expected return.

Did you try this?

Run Content Syndication Now

   

Content Syndication

Quickly integrate customizable finance content to your own investment portal
All  Next Launch Module

Complementary Tools for Beyond Stock analysis

When running Beyond Medical's price analysis, check to measure Beyond Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Beyond Medical is operating at the current time. Most of Beyond Medical's value examination focuses on studying past and present price action to predict the probability of Beyond Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Beyond Medical's price. Additionally, you may evaluate how the addition of Beyond Medical to your portfolios can decrease your overall portfolio volatility.
Investing Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments
Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios